CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

News Charles River Laboratories International, Inc. Deutsche Boerse AG

Equities

RV6

US1598641074

Market Closed - Deutsche Boerse AG Other stock markets 11:37:56 10/05/2024 am IST			5-day change	1st Jan Change
212.9 ^EUR	-2.38%		-0.42%	-0.56%

10/05	JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	MT
10/05	Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	10/05	MT
Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	10/05	MT
Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300	10/05	MT
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282	10/05	MT
Transcript : Charles River Laboratories International, Inc., Q1 2024 Earnings Call, May 09, 2024	09/05
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance	09/05	MT
Charles River Laboratories International, Inc. Reports Impairment Charges for the First Quarter Ended March 30, 2024	09/05	CI
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	09/05	CI
Earnings Flash (CRL) CHARLES RIVER LABORATORIES INTERNATIONAL Reports Q1 Adjusted EPS $2.27	09/05	MT
Stocks Down Pre-Bell Ahead of Latest Earnings Results; Asia, Europe Churn	09/05	MT
Earnings Flash (CRL) CHARLES RIVER LABORATORIES INTERNATIONAL Posts Q1 Revenue $1.01B	09/05	MT
(CRL) CHARLES RIVER LABORATORIES INTERNATIONAL Expects Fiscal Year 2024 Adjusted EPS Range $10.90 - $11.40	09/05	MT
Charles River: Q1 Earnings Snapshot	09/05	AQ
Charles River Laboratories Announces First-Quarter 2024 Results	09/05	BU
Charles River Laboratories International, Inc. Revises Financial Guidance for 2024	09/05	CI
China trade heats up, UK rates in view	09/05	RE
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP	02/05	BU
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids	25/04	CI
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024	24/04	PU
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission	24/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Charles River Laboratories International, Inc. Deutsche Boerse AG

Equities

RV6

US1598641074

Summary

Filters